Pfizer Sees 2021 Adjusted Earnings Ahead of Street Views
13 January 2021 - 4:32AM
Dow Jones News
By Colin Kellaher
Pfizer Inc. on Tuesday said it expects earnings this year will
top Wall Street forecasts amid surging demand for its Covid-19
vaccine.
The New York drugmaker expects adjusted full-year earnings of
$3.00 to $3.10 a share, Chairman and Chief Executive Albert Bourla
said at a conference.
Analysts polled by FactSet, on average, were expecting Pfizer to
post an adjusted profit of $2.96 a share in 2021.
In a filing with the U.S. Securities and Exchange Commission,
Pfizer noted that its forecast reflects its current expectations
and assumptions regarding the impact of the Covid-19 pandemic,
including its vaccine supply and contracts, which the company said
remain dynamic.
BioNTech SE, Pfizer's partner on the Covid-19 vaccine, on Monday
said the companies were aiming to supply up to two billion doses of
the vaccine this year.
Pfizer said it will provide more detailed guidance on Feb. 2,
when it reports its fourth-quarter results.
Shares of Pfizer were recently down 2.2% at $36.94.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
January 12, 2021 12:17 ET (17:17 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Apr 2023 to Apr 2024
